Cornerstone Wealth Management, LLC Mannkind Corp Transaction History

Cornerstone Wealth Management, LLC

  • $1.39 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 13, 2019
SELL
$1.02 - $2.05 $1,087 - $2,185
-1,066 Closed
0 $0
Q3 2018

Oct 19, 2018
SELL
$1.01 - $2.19 $842 - $1,826
-834 Reduced 43.89%
1,066 $200,000
Q2 2018

Jul 20, 2018
BUY
$1.59 - $2.38 $3,021 - $4,522
1,900 New
1,900 $1 Million

Others Institutions Holding MNKD

# of Institutions
243
Shares Held
148M
Call Options Held
1.62M
Put Options Held
802K
View Full List

About MANNKIND CORP

MNKD Quotes by TradingView
  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.55B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Cornerstone Wealth Management, LLC Portfolio

Follow Cornerstone Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email